CORRECTION article

Front. Cell Dev. Biol., 09 September 2022

Sec. Molecular and Cellular Pathology

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1002132

Corrigendum: Oxymatrine attenuates osteoclastogenesis via modulation of ROS-mediated SREBP2 signaling and counteracts ovariectomy-induced osteoporosis

  • CJ

    Chao Jiang 1,2

  • QM

    Qingliang Ma 1,2

  • SW

    Shiyu Wang 1,2

  • YS

    Yang Shen 1,2

  • AQ

    An Qin 3

  • SF

    Shunwu Fan 1,2

  • ZJ

    Zhiwei Jie 1,2*

  • 1. Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

  • 2. Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou, China

  • 3. Department of Orthopaedics, Shanghai Key Laboratory of Orthopaedic Implant, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

In the original article, there were mistakes in Figures 1, 3 as published. The scale bars of TRAP staining images in Figures 1D, 3J were incorrect. Furthermore, we applied a mismatched picture for Figure 1F. The corrected Figures 1, 3 appear below.

FIGURE 1

FIGURE 3

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

oxymatrine, osteoclast, ROS, SREBP2, osteoporosis

Citation

Jiang C, Ma Q, Wang S, Shen Y, Qin A, Fan S and Jie Z (2022) Corrigendum: Oxymatrine attenuates osteoclastogenesis via modulation of ROS-mediated SREBP2 signaling and counteracts ovariectomy-induced osteoporosis. Front. Cell Dev. Biol. 10:1002132. doi: 10.3389/fcell.2022.1002132

Received

25 July 2022

Accepted

18 August 2022

Published

09 September 2022

Volume

10 - 2022

Edited and reviewed by

Claudia Fiorillo, University of Florence, Italy

Updates

Copyright

*Correspondence: Zhiwei Jie,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics